Bipolar Disorder Treatment in West Palm Beach

The intake covers the DSM-5-TR criteria for bipolar I, bipolar II, and cyclothymia. An MDQ hypomania screen catches what self-report tends to miss, family history is mapped carefully, and prior medication trials are reviewed because SSRI-induced agitation or insomnia is a clinically meaningful clue. Collateral information from a partner or family member is welcomed when available. The 60-minute initial visit holds the assessment and the early treatment-plan conversation.

Bipolar I requires at least one full manic episode — elevated or irritable mood, decreased need for sleep, racing thoughts, impulsive decisions, and functional impairment lasting at least seven days. Bipolar II runs on hypomania — the same pattern, less severe, lasting four days or more — paired with depressive episodes. Bipolar II is more often missed because hypomania can feel like the productive version of you; the depressive crash is the side that drives most patients into care.

Bipolar is a chronic, relapsing condition. The standard recommendation after a single manic episode is maintenance medication for at least 6–12 months; after recurrent episodes, long-term maintenance is the standard. Discontinuation carries a real relapse risk — lithium discontinuation specifically increases short-term suicide risk. Any taper is a prescriber decision made deliberately, not a self-managed step.

Alcohol is discouraged on lithium for two reasons: it raises relapse risk on the mood side and it changes hydration in ways that can push lithium levels out of the therapeutic window. Lithium narrow therapeutic range (0.6–1.2 mEq/L) means dehydration from heavy drinking can drive a level into the toxic range. Occasional moderate use is a case-by-case conversation; binge use sits outside the safe envelope.

Each mood stabilizer carries its own profile. Lithium: tremor, thirst, weight, possible thyroid and renal effects over years. Valproate: weight, hair thinning, liver and platelet monitoring, teratogenicity. Lamotrigine: well-tolerated once titrated, with rash watch in the first eight weeks (Stevens-Johnson syndrome risk). Atypicals: variable weight and metabolic effects; lurasidone and aripiprazole are typically weight-neutral, olanzapine and quetiapine less so. The visit conversation matches the medication choice to the side-effect profile you can live with.

Acute mania presents with elevated or irritable mood, racing thoughts, decreased need for sleep without fatigue, pressured speech, grandiosity, and impulsive decisions — spending, sexual, occupational. Severe mania with psychosis, aggression, or inability to maintain safety is an inpatient-level emergency, not an outpatient case. Stable-phase maintenance and earlier-stage breakthrough are outpatient. The intake includes a frank conversation about which side of that line the current presentation sits on.

Yes, for follow-up and maintenance visits. Initial bipolar evaluations are typically done in-office or via video with collateral involvement so that the diagnostic picture is built carefully. Once stabilizer titration is past the initial phase, monthly follow-ups by telepsychiatry across Florida are routine. Lab orders route to your local reference lab regardless of visit format.

Pregnancy on bipolar medication is a planned conversation, not an emergency one. Valproate carries the highest teratogenicity (neural tube defects) and is generally avoided in women of childbearing age. Lithium first-trimester exposure raises Ebstein anomaly risk (rare, monitored by fetal echo). Lamotrigine has a relatively favorable profile. Untreated bipolar in pregnancy carries its own significant risk — relapse, postpartum mania, suicide — so the decision is a weighed comparison, not a default discontinuation. Planning before conception when possible.